FDA Inspection 1262211 — Pharmacosmos A/S
The FDA completed an inspection of Pharmacosmos A/S on October 14, 2022 in Holbak. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- October 14, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Holbak (Denmark)
Additional Details
Mutual Recognition Agreement (MRA)